PL1976538T3 - Preparat farmaceutyczny do leczenia choroby zwyrodnieniowej stawów zawierający kwas klodronowy i kwas hialuronowy - Google Patents

Preparat farmaceutyczny do leczenia choroby zwyrodnieniowej stawów zawierający kwas klodronowy i kwas hialuronowy

Info

Publication number
PL1976538T3
PL1976538T3 PL06841087T PL06841087T PL1976538T3 PL 1976538 T3 PL1976538 T3 PL 1976538T3 PL 06841087 T PL06841087 T PL 06841087T PL 06841087 T PL06841087 T PL 06841087T PL 1976538 T3 PL1976538 T3 PL 1976538T3
Authority
PL
Poland
Prior art keywords
acid
treatment
pharmaceutical formulation
hyaluronic acid
osteoarthritis containing
Prior art date
Application number
PL06841087T
Other languages
English (en)
Inventor
Sergio Rosini
Silvia Trasciatti
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Publication of PL1976538T3 publication Critical patent/PL1976538T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
PL06841087T 2005-12-29 2006-12-21 Preparat farmaceutyczny do leczenia choroby zwyrodnieniowej stawów zawierający kwas klodronowy i kwas hialuronowy PL1976538T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002515A ITMI20052515A1 (it) 2005-12-29 2005-12-29 Formulazione farmaceutica per il trattamento della osteoartrite
EP06841087A EP1976538B1 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
PCT/EP2006/012367 WO2007073921A1 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Publications (1)

Publication Number Publication Date
PL1976538T3 true PL1976538T3 (pl) 2010-03-31

Family

ID=36648609

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06841087T PL1976538T3 (pl) 2005-12-29 2006-12-21 Preparat farmaceutyczny do leczenia choroby zwyrodnieniowej stawów zawierający kwas klodronowy i kwas hialuronowy

Country Status (21)

Country Link
US (4) US20090042833A1 (pl)
EP (1) EP1976538B1 (pl)
JP (1) JP2009522218A (pl)
KR (2) KR20140107651A (pl)
AT (1) ATE446763T1 (pl)
AU (1) AU2006331019B2 (pl)
CA (1) CA2646974C (pl)
CY (1) CY1109541T1 (pl)
DE (1) DE602006010111D1 (pl)
DK (1) DK1976538T3 (pl)
ES (1) ES2333615T3 (pl)
HK (1) HK1123986A1 (pl)
IT (1) ITMI20052515A1 (pl)
NO (1) NO340794B1 (pl)
NZ (1) NZ569420A (pl)
PL (1) PL1976538T3 (pl)
PT (1) PT1976538E (pl)
RU (1) RU2414908C2 (pl)
SI (1) SI1976538T1 (pl)
WO (1) WO2007073921A1 (pl)
ZA (1) ZA200805598B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103260628B (zh) * 2010-10-07 2015-07-29 成功大学 透明质酸用于促进血管生成的用途
CN118161529A (zh) 2014-11-07 2024-06-11 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
KR101706642B1 (ko) 2015-02-04 2017-02-17 주식회사 엑소스템텍 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
IT202100023894A1 (it) * 2021-09-16 2023-03-16 Professional Derma Sa Composizione per utilizzo in campo ortopedico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JP2001253827A (ja) * 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
CN1180846C (zh) * 2000-05-05 2004-12-22 霍夫曼-拉罗奇有限公司 含有双膦酸或其盐的,用于皮下给药的凝胶体状药物组合物
EP1519744A4 (en) * 2002-05-17 2007-10-03 Wyeth Corp INJECTABLE SOLID HYALURONIC ACID CARRIER FOR THE ADMISSION OF OSTEOGEN PROTEINS
KR100648515B1 (ko) * 2004-05-04 2006-11-27 (주)아모레퍼시픽 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제

Also Published As

Publication number Publication date
US20090042833A1 (en) 2009-02-12
NZ569420A (en) 2010-05-28
RU2008126108A (ru) 2010-01-10
EP1976538A1 (en) 2008-10-08
AU2006331019B2 (en) 2012-03-22
CA2646974A1 (en) 2007-07-05
ES2333615T3 (es) 2010-02-24
US20200147126A1 (en) 2020-05-14
WO2007073921A1 (en) 2007-07-05
DE602006010111D1 (de) 2009-12-10
JP2009522218A (ja) 2009-06-11
CY1109541T1 (el) 2014-08-13
KR101470608B1 (ko) 2014-12-09
NO340794B1 (no) 2017-06-19
US20140371170A1 (en) 2014-12-18
DK1976538T3 (da) 2010-01-11
US20180185407A1 (en) 2018-07-05
ZA200805598B (en) 2009-11-25
ITMI20052515A1 (it) 2007-06-30
AU2006331019A1 (en) 2007-07-05
RU2414908C2 (ru) 2011-03-27
ATE446763T1 (de) 2009-11-15
HK1123986A1 (en) 2009-07-03
CA2646974C (en) 2013-06-11
SI1976538T1 (sl) 2010-01-29
US9943540B2 (en) 2018-04-17
AU2006331019A2 (en) 2009-01-22
EP1976538B1 (en) 2009-10-28
KR20080082657A (ko) 2008-09-11
KR20140107651A (ko) 2014-09-04
PT1976538E (pt) 2009-12-07
NO20082848L (no) 2008-08-27

Similar Documents

Publication Publication Date Title
HK1219023A1 (zh) 含有游離脂肪酸和/或游離脂肪酸衍生物的微乳液形式組合物
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
MY143795A (en) Tetrahydropyridoindole derivatives
UA100228C2 (uk) Фармацевтична композиція, яка містить тетрагідрофолієву кислоту
TW200738659A (en) Novel compounds
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
WO2011041461A3 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
WO2011041694A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2011017350A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2009120365A3 (en) Methods and compositions for the delivery of agents
WO2006086562A3 (en) Phenylazetidinone derivatives
TN2011000245A1 (en) Organic compounds
TW200640908A (en) Chemical compounds
BRPI0511478A (pt) composições de vidro como aditivo antimicrobiano para materiais dentários
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
NO20075111L (no) Farmasoytisk sammensetning
TNSN07322A1 (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
MX2009008542A (es) Agentes de suministro de acido fenilalquilcarboxilico.
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
HK1123986A1 (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
MXPA05011785A (es) Moduladores positivos de receptores de acetilcolina nicotinicos.
WO2007068473A3 (en) Organic compounds